Showing results (41-50 of 131) with videos related to
Sort By:
Pageof 14
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2013
Biomarker tests for the diagnosis of Alzheimer's disease: Generating evidence to inform insurance coverage determinationsSteven D Pearson, Daniel A Ollendorf, Jennifer A Colby, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 14, 2018
Evaluating and Valuing Drugs for Rare Conditions: No Easy AnswersDaniel A Ollendorf, Richard H Chapman, Steven D PearsonJournal of Comparative Effectiveness Research|July 11, 2025
Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the USSteven D Pearson, Christopher M Whaley, Sarah K EmondJournal of Comparative Effectiveness Research|November 14, 2024
Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United StatesSharon Phares, Mark Trusheim, Sarah K Emond, et al.Journal of Comparative Effectiveness Research|July 13, 2017
Indication-specific pricing of pharmaceuticals in the US healthcare systemSteven D Pearson, William B Dreitlein, Chris Henshall, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
On Track: a database for evaluating the outpatient clinical experience of internal medicine residency trainingThomas D Sequist, Surya Singh, Anne Pereira, et al.Journal of Managed Care & Specialty Pharmacy|May 29, 2019
A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory CouncilIfeoma S Otuonye, Reiner Banken, Varun M Kumar, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 28, 2024
How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative StudyMichael J DiStefano, Steven D Pearson, David M Rind, et al.Journal of Comparative Effectiveness Research|September 28, 2019
Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy SummitSteven D Pearson, Celia Segel, Amanda Cole, et al.Journal of Managed Care & Specialty Pharmacy|April 1, 2020
The Authors RespondDaniel R Touchette, Foluso Agboola, Steven J Atlas, et al.Pageof 14